China Resources Shuanghe: Compound polyethylene glycol electrolyte powder obtained drug registration certificate.

Notice from CR Double Crane: Recently, the company received the Drug Registration Certificate for the compound polyethylene glycol electrolyte powder issued by the National Medical Products Administration. The compound polyethylene glycol electrolyte powder is used to treat chronic constipation in children aged 1 to 11. It is used to treat fecal impaction in children aged 5 to 11, which includes stubborn constipation with rectal and/or colon fecal blockage. The company initiated the development of generic drugs for this product in January 2023, submitted the application for market approval to the National Medical Products Administration on July 22, 2024, received the acceptance notice on July 29, 2024, and obtained approval for market entry from the National Medical Products Administration on June 17, 2026. According to relevant national policies, obtaining the Drug Registration Certificate this time is equivalent to passing the consistency evaluation.